BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34841494)

  • 1. A collaborative genetic carrier screening model for the British Ashkenazi Jewish community.
    Ziff M; Harris J
    J Community Genet; 2022 Feb; 13(1):133-135. PubMed ID: 34841494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The frequency of Tay-Sachs disease causing mutations in the Brazilian Jewish population justifies a carrier screening program.
    Rozenberg R; Pereira Lda V
    Sao Paulo Med J; 2001 Jul; 119(4):146-9. PubMed ID: 11500789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lessons learned from expanded reproductive carrier screening in self-reported Ashkenazi, Sephardi, and Mizrahi Jewish patients.
    Akler G; Birch AH; Schreiber-Agus N; Cai X; Cai G; Shi L; Yu C; Larmore AM; Mendiratta-Vij G; Elkhoury L; Dillon MW; Zhu J; Mclellan AS; Suer FE; Webb BD; Schadt EE; Kornreich R; Edelmann L
    Mol Genet Genomic Med; 2020 Feb; 8(2):e1053. PubMed ID: 31880409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carrier screening for cystic fibrosis, Gaucher disease, and Tay-Sachs disease in the Ashkenazi Jewish population: the first 1000 cases at New York University Medical Center, New York, NY.
    Kronn D; Jansen V; Ostrer H
    Arch Intern Med; 1998 Apr; 158(7):777-81. PubMed ID: 9554684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Joint SOGC-CCMG Opinion for Reproductive Genetic Carrier Screening: An Update for All Canadian Providers of Maternity and Reproductive Healthcare in the Era of Direct-to-Consumer Testing.
    Wilson RD; De Bie I; Armour CM; Brown RN; Campagnolo C; Carroll JC; Okun N; Nelson T; Zwingerman R; Audibert F; Brock JA; Brown RN; Campagnolo C; Carroll JC; De Bie I; Johnson JA; Okun N; Pastruck M; Vallée-Pouliot K; Wilson RD; Zwingerman R; Armour C; Chitayat D; De Bie I; Fernandez S; Kim R; Lavoie J; Leonard N; Nelson T; Taylor S; Van Allen M; Van Karnebeek C
    J Obstet Gynaecol Can; 2016 Aug; 38(8):742-762.e3. PubMed ID: 27638987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a multi-disease carrier screening programme in Ashkenazi Jewish high schools.
    Ioannou L; Massie J; Lewis S; Petrou V; Gason A; Metcalfe S; Aitken MA; Bankier A; Delatycki MB
    Clin Genet; 2010 Jul; 78(1):21-31. PubMed ID: 20597919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond the "Jewish panel": the importance of offering expanded carrier screening to the Ashkenazi Jewish population.
    Dolitsky S; Mitra A; Khan S; Ashkinadze E; Sauer MV
    F S Rep; 2020 Dec; 1(3):294-298. PubMed ID: 34223259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carrier screening in the Mexican Jewish community using a pan-ethnic expanded carrier screening NGS panel.
    Morgenstern-Kaplan D; Raijman-Policar J; Majzner-Aronovich S; Aradhya S; Pineda-Alvarez DE; Aguinaga M; García-Vences EE
    Genet Med; 2022 Apr; 24(4):821-830. PubMed ID: 34961661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACOG Committee Opinion No. 442: Preconception and prenatal carrier screening for genetic diseases in individuals of Eastern European Jewish descent.
    Obstet Gynecol; 2009 Oct; 114(4):950. PubMed ID: 19888064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Creation of a National, At-home Model for Ashkenazi Jewish Carrier Screening.
    Grinzaid KA; Page PZ; Denton JJ; Ginsberg J
    J Genet Couns; 2015 Jun; 24(3):381-7. PubMed ID: 25502003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do people from the Jewish community prefer ancestry-based or pan-ethnic expanded carrier screening?
    Holtkamp KC; van Maarle MC; Schouten MJ; Dondorp WJ; Lakeman P; Henneman L
    Eur J Hum Genet; 2016 Feb; 24(2):171-7. PubMed ID: 25966636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the model of offering expanded genetic carrier screening to high school students within the Sydney Jewish community.
    Barlow-Stewart K; Bardsley K; Elan E; Fleming J; Berman Y; Fleischer R; Recsei K; Goldberg D; Tucker J; Burnett L
    J Community Genet; 2022 Feb; 13(1):121-131. PubMed ID: 34846685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a Tay-Sachs disease screening program.
    Gason AA; Sheffield E; Bankier A; Aitken MA; Metcalfe S; Barlow Stewart K; Delatycki MB
    Clin Genet; 2003 May; 63(5):386-92. PubMed ID: 12752571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population-based Tay-Sachs screening among Ashkenazi Jewish young adults in the 21st century: Hexosaminidase A enzyme assay is essential for accurate testing.
    Schneider A; Nakagawa S; Keep R; Dorsainville D; Charrow J; Aleck K; Hoffman J; Minkoff S; Finegold D; Sun W; Spencer A; Lebow J; Zhan J; Apfelroth S; Schreiber-Agus N; Gross S
    Am J Med Genet A; 2009 Nov; 149A(11):2444-7. PubMed ID: 19876898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for carriers of Tay-Sachs disease in the ultraorthodox Ashkenazi Jewish community in Israel.
    Broide E; Zeigler M; Eckstein J; Bach G
    Am J Med Genet; 1993 Aug; 47(2):213-5. PubMed ID: 8213907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tay-Sachs disease: current perspectives from Australia.
    Lew RM; Burnett L; Proos AL; Delatycki MB
    Appl Clin Genet; 2015; 8():19-25. PubMed ID: 25653550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tay-Sachs disease preconception screening in Australia: self-knowledge of being an Ashkenazi Jew predicts carrier state better than does ancestral origin, although there is an increased risk for c.1421 + 1G > C mutation in individuals with South African heritage.
    Lew R; Burnett L; Proos A
    J Community Genet; 2011 Dec; 2(4):201-9. PubMed ID: 22109873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of enzyme and DNA analysis in a Tay-Sachs disease carrier screening program.
    Yoo HW; Astrin KH; Desnick RJ
    J Korean Med Sci; 1993 Feb; 8(1):84-91. PubMed ID: 8343225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of the Tay-Sachs disease splice and insertion mutations in the UK Ashkenazi Jewish population.
    Landels EC; Ellis IH; Fensom AH; Green PM; Bobrow M
    J Med Genet; 1991 Mar; 28(3):177-80. PubMed ID: 1828838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tay Sachs disease in Australia: reduced disease incidence despite stable carrier frequency in Australian Jews.
    Lew RM; Proos AL; Burnett L; Delatycki M; Bankier A; Fietz MJ
    Med J Aust; 2012 Dec; 197(11):652-4. PubMed ID: 23230938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.